Neurological Toxicities and Coagulation Disorders in the Cytokine Release Syndrome During CAR-T Therapy

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14680
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Cytokine Release Syndrome and Neurotoxicity After CD19 Chimeric Antigen Receptor-Modified (CAR-) T Cell Therapy

British Journal of Haematology
Hematology
2018English

Cytokine Release Syndrome With Chimeric Antigen Receptor T Cell Therapy

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Granulocyte-Macrophage Colony-Stimulating Factor Inactivation in CAR T-Cells Prevents Monocyte-Dependent Release of Key Cytokine Release Syndrome Mediators

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2019English

Toxicities of CD19 CAR-T Cell Immunotherapy

American Journal of Hematology
Hematology
2019English

Prediction of CAR T-Related Toxicities in R/R DLBCL Patients Treated With Axicabtagene Ciloleucel Using Point of Care Cytokine Measurements

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Progress in Gene Therapy for Neurological Disorders

Nature Reviews Neurology
Molecular NeuroscienceNeurologyCellular
2013English

Next Frontiers in CAR T-Cell Therapy

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

A Catecholamine Loop Mediates Cytokine Release Syndrome

Cancer Discovery
Oncology
2019English

Correlative Analyses of Cytokine Release Syndrome and Neurological Events in Tisagenlecleucel-Treated Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy